Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Hepatic Surgery(Electronic Edition) ›› 2023, Vol. 12 ›› Issue (06): 635-639. doi: 10.3877/cma.j.issn.2095-3232.2023.06.009

• Clinical Research • Previous Articles     Next Articles

Safety and efficacy of laparoscopic sleeve gastrectomy combined with cholecystectomy in treatment of obesity complicated with cholecystolithiasis

Zhao Niu, Bo Li, Wanfu Zhang, Wendi Jin, Chunxiao Wang, Xiaogang Li()   

  1. Department Ⅰ of General Surgery, Affiliated Hospital of Yunnan University, Kunming 650021, China
  • Received:2023-09-04 Online:2023-12-10 Published:2023-11-23
  • Contact: Xiaogang Li

Abstract:

Objective

To evalute the safety and efficacy of laparoscopic sleeve gastrectomy (LSG) combined with laparoscopic cholecystectomy (LC) in the treatment of obese patients complicated with cholecystolithiasis.

Methods

Clinical data of 32 patients with obesity complicated with cholecystolithiasis who underwent LSG combined with LC in the Affiliated Hospital of Yunnan University from January 2020 to January 2022 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 8 patients were male and 24 female, aged from 20 to 55 years, with a median age of 34 years. Operative complications and clinical efficacy at postoperative 6 months were observed. Preoperative and postoperative BMI, lipid level, glucose level and blood pressure were compared by t test.

Results

LSG combined with LC was successfully performed in all patients. No evident complications, such as postoperative bleeding, gastric fistula, bile leakage, biliary tract injury and gastric cavity stenosis, were recorded during perioperative period. Preoperative body weight was (97±13) kg, which was decreased to (70±9) kg at postoperative 6 months. Preoperative BMI was (35.6±6.4) kg/m2, which was declined to (23.2±1.3) kg/m2 after surgery. In 28 patients with hyperlipidemia, preoperative lipid level was (12.8±7.5) mmol/L and decreased to (2.2±1.1) mmol/L after surgery. In 12 patients with type 2 diabetes mellitus, preoperative fasting glucose level was (12.5±1.7) mmol/L and decreased to (5.5±0.9) mmol/L postoperatively. In 10 patients with hypertension, preoperative blood pressure level was (168±13)/(104±9) mmHg and declined to (138±11)/(90±6) mmHg after surgery (1 mmHg=0.133 kPa)(t=8.641, 8.505, 31.272, 10.443, 8.862, 8.414; P<0.05).

Conclusions

It is safe and feasible to perform LSG combined with LC for obese patients complicated with cholecystolithiasis, which can remarkably mitigate metabolic diseases, such as obesity, hyperlipidemia, hypertension and hyperglycemia, etc. LSG combined with LC yields equivalent efficacy to that of LSG or LC alone, whereas it has advantages in alleviating trauma and lowering surgical cost, etc.

Key words: Sleeve gastrectomy, Cholecystectomy, laparoscopic, Cholecystolithiasis, Weight loss

京ICP 备07035254号-20
Copyright © Chinese Journal of Hepatic Surgery(Electronic Edition), All Rights Reserved.
Tel: 020-85252582 85252369 E-mail: chinaliver@126.com
Powered by Beijing Magtech Co. Ltd